Rhumbline Advisers Penumbra Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Penumbra Inc stock. As of the latest transaction made, Rhumbline Advisers holds 109,537 shares of PEN stock, worth $26.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

109,537

Previous 109,132 0.37%

Holding current value

$26.1 Million

Previous $19.6 Million 8.28%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.64 - $210.12 $66,274 - $85,098	405 Added 0.37%	109,537 $21.3 Million
Q2 2024 Aug 01, 2024	BUY	$172.27 - $223.95 $89,063 - $115,782	517 Added 0.48%	109,132 $19.6 Million
Q1 2024 May 09, 2024	SELL	$220.09 - $273.15 $895,986 - $1.11 Million	-4,071 Reduced 3.61%	108,615 $24.2 Million
Q4 2023 Feb 08, 2024	SELL	$181.44 - $260.22 $832,265 - $1.19 Million	-4,587 Reduced 3.91%	112,686 $28.3 Million
Q3 2023 Nov 09, 2023	SELL	$240.69 - $338.77 $118,178 - $166,336	-491 Reduced 0.42%	117,273 $28.4 Million
Q2 2023 Aug 08, 2023	BUY	$271.54 - $344.06 $1.13 Million - $1.43 Million	4,164 Added 3.67%	117,764 $40.5 Million
Q1 2023 May 11, 2023	BUY	$220.43 - $278.69 $730,284 - $923,299	3,313 Added 3.0%	113,600 $31.7 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $650,653 - $978,894	4,284 Added 4.04%	110,287 $24.5 Million
Q3 2022 Nov 10, 2022	BUY	$120.36 - $205.88 $902,579 - $1.54 Million	7,499 Added 7.61%	106,003 $20.1 Million
Q2 2022 Aug 11, 2022	BUY	$116.09 - $227.33 $986,532 - $1.93 Million	8,498 Added 9.44%	98,504 $12.3 Million
Q1 2022 May 12, 2022	SELL	$187.51 - $283.98 $31,689 - $47,992	-169 Reduced 0.19%	90,006 $20 Million
Q4 2021 Feb 10, 2022	BUY	$238.08 - $288.0 $509,967 - $616,896	2,142 Added 2.43%	90,175 $25.9 Million
Q3 2021 Nov 12, 2021	SELL	$250.72 - $291.24 $20,559 - $23,881	-82 Reduced 0.09%	88,033 $23.5 Million
Q2 2021 Aug 05, 2021	SELL	$235.0 - $310.7 $411,955 - $544,657	-1,753 Reduced 1.95%	88,115 $24.1 Million
Q1 2021 May 06, 2021	SELL	$175.6 - $291.43 $141,358 - $234,601	-805 Reduced 0.89%	89,868 $24.3 Million
Q4 2020 Feb 10, 2021	SELL	$174.98 - $272.83 $660,724 - $1.03 Million	-3,776 Reduced 4.0%	90,673 $15.9 Million
Q3 2020 Nov 12, 2020	SELL	$185.27 - $238.73 $434,643 - $560,060	-2,346 Reduced 2.42%	94,449 $18.4 Million
Q2 2020 Aug 13, 2020	BUY	$153.32 - $191.72 $1.12 Million - $1.4 Million	7,289 Added 8.14%	96,795 $17.3 Million
Q1 2020 May 06, 2020	SELL	$124.34 - $193.76 $162,139 - $252,663	-1,304 Reduced 1.44%	89,506 $14.4 Million
Q4 2019 Feb 05, 2020	BUY	$134.81 - $177.8 $79,537 - $104,902	590 Added 0.65%	90,810 $14.9 Million
Q3 2019 Oct 23, 2019	BUY	$131.82 - $183.4 $7.32 Million - $10.2 Million	55,538 Added 160.13%	90,220 $12.1 Million
Q2 2019 Aug 14, 2019	BUY	$124.65 - $167.39 $100,841 - $135,418	809 Added 2.39%	34,682 $5.55 Million
Q1 2019 May 01, 2019	SELL	$115.84 - $160.31 $244,654 - $338,574	-2,112 Reduced 5.87%	33,873 $4.98 Million
Q4 2018 Jan 31, 2019	BUY	$113.42 - $156.48 $281,848 - $388,852	2,485 Added 7.42%	35,985 $4.4 Million
Q3 2018 Nov 07, 2018	SELL	$121.55 - $156.8 $933,868 - $1.2 Million	-7,683 Reduced 18.66%	33,500 $5.02 Million
Q2 2018 Aug 06, 2018	BUY	$112.2 - $165.95 $1.52 Million - $2.24 Million	13,523 Added 48.89%	41,183 $5.69 Million
Q1 2018 May 02, 2018	SELL	$84.6 - $126.1 $63,703 - $94,953	-753 Reduced 2.65%	27,660 $3.2 Million
Q4 2017 Feb 09, 2018	SELL	$91.55 - $115.85 $452,073 - $572,067	-4,938 Reduced 14.81%	28,413 $2.67 Million
Q3 2017 Nov 06, 2017	BUY	$79.65 - $90.3 $2.66 Million - $3.01 Million	33,351	33,351 $3.01 Million

Others Institutions Holding PEN

# of Institutions

372

Shares Held

29.1M

Call Options Held

305K

Put Options Held

192K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Penumbra Inc Transaction History